Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,508,985
-
Share change
-
-2,092,596
-
Total reported value
-
$2,316,771
-
Put/Call ratio
-
771%
-
Price per share
-
$0.92
-
Number of holders
-
25
-
Value change
-
-$1,548,385
-
Number of buys
-
8
-
Number of sells
-
10
Institutional Holders of ACER THERAPEUTICS INC - COM (ACER) as of Q2 2023
As of 30 Jun 2023,
ACER THERAPEUTICS INC - COM (ACER) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,508,985 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, VANGUARD GROUP INC, Hudson Bay Capital Management LP, Anson Funds Management LP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, BlackRock Inc., HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, and STATE STREET CORP.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.